Respiratory syncytial virus vaccines

AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL

120mcg/0.5mL injection, powder, lyophilized, for liposomal suspensionSingaporeAuthorisedAuthorised 10 May 2024

In other countries

The same active substances on other registers, the same brand first.

ArexvyCanada · 120 MCG / 0.5 ML · Powder For Suspension · Glaxosmithkline INCSame brand
ArexvyEuropean Union · GlaxoSmithKline Biologicals S.A.Same brand
Arexvy, cjepivo protiv respiratornog sincicijskog virusa (RSV) (rekombinantno, adjuvantirano)CroatiaSame brand
ArexvyItaly · Polvere e sospensione per sospensione iniettabile · Glaxosmithkline Biologicals S.A.Same brand
Arexvy, poeder en suspensie voor suspensie voor injectieNetherlands · Poeder en suspensie voor suspensie voor injectie · GlaxoSmithKline Biologicals S.A.Same brand
AbrysvoItaly · Polvere e solvente per soluzione iniettabile · Pfizer Europe Ma EeigSame form
MresviaItaly · Dispersione per preparazione iniettabile · Moderna Biotech Spain, S.L.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Respiratory syncytial virus vaccines

AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL

120mcg/0.5mL injection, powder, lyophilized, for liposomal suspensionSingaporeAuthorisedAuthorised 10 May 2024

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

mRESVIA dispersie voor injectie in een voorgevulde spuit mRNA-vaccin tegen het respiratoir syncytieel virusNetherlands · Dispersie voor injectie · Moderna Biotech Spain S.L.

AbrysvoUnited States · 120UG · Injection · Pfizer Inc.

mresviaUnited States · 50UG/.5ML · For Injection · ModernaTX, Inc.

MresviaCanada · 50 MCG / 0.5 ML · Dispersion · Moderna Biopharma Canada Corporation

AbrysvoEuropean Union · Pfizer Europe MA EEIG

mResviaEuropean Union · Moderna Biotech Spain, S.L.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence 1.0 · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Respiratory syncytial virus vaccines
Strength: 120mcg/0.5mL
Dosage form: injection, powder, lyophilized, for liposomal suspension
Route: intramuscular
Register: Singapore (HSA)
Status: Authorised
Status in the register: Registered
Authorised: 10 May 2024
Registration: SIN17008P
Marketing authorisation holder: Glaxosmithkline Pte LTD
Manufacturer: GlaxoSmithKline Biologicals SA / GlaxoSmithKline Biologicals SA (adjuvant) / GlaxoSmithKline Vaccines S.r.l. (adjuvant) / GlaxoSmithKline Biologicals SA (adjuvant), BELGIUM / ITALY
ATC code: J07BX05
Group: Anti-infectives for systemic use
Supply: Prescription Only